A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Hepatitis A IgM Antibody
Test CodeAlias/See Also
CPT Codes
86709
Preferred Specimen
Serum (gold top tube)
Minimum Volume
Other Acceptable Specimens
Transport Container
Serum (gold top) or Lithium Heparin Plasma (green top) Tube
Transport Temperature
Specimen Stability
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Methodology
Chemiluminescence
Setup Schedule
Daily Upon Receipt
Report Available
Limitations
Reference Range
Interpretation:
Negative: Non-reactive for Hepatitis A IgM antibodies; does not rule out infection with Hepatitis A, as levels of Hepatitis A IgM antibodies may be below the cutoff. Retest in 2 weeks if Hepatitis A is suspected in early infection stages. In addition, if testing is performed several weeks to months after infection, it is possible that Hepatitis A IgM antibodies have already risen to peak levels and have now fallen below detectable levels. Does not rule out other types of viral hepatitis.
Equivocal: Sample is Borderline Reactive for anti-HAV IgM antibodies. It is recommended that a new specimen be obtained in two weeks and retested.
Positive: Specimen is presumed positive for Hepatitis A IgM Antibodies
Clinical Significance
IgM antibodies against HAV are detected soon after the onset of symptoms. Persistence of the IgM response is extremely variable, with specific IgM detected for less than one month in some cases to greater than one year in others. In most cases, IgM antibodies against HAV persist for a period of three to six months after which they decline to levels that are below detection. The Anti-HAV IgM assay is designed to detect anti-HAV IgM as a laboratory diagnosis of acute or recent hepatitis A infection. The detection of anti-HAV IgM can be useful for the differential diagnosis of hepatitis A from other forms of viral hepatitis. Testing with other hepatitis markers is required.